State and local governments should embrace farmers market managers’ input on food regulation during the pandemic.
Scholars call for greater transparency in how FDA uses subjective evidence in treatments for brain injuries.
Scholar examines the institutional review board process for resolving disputes in human subjects research.
The federal government seeks to improve out-of-state health services for children on Medicaid.
States developing public options may offer the federal government valuable lessons in expanding access to care at a lower cost.
The COVID-19 pandemic raises questions about how decision-makers should distribute medical resources.
With medical systems overwhelmed during the pandemic, telemedicine could be here to stay.
FDA releases guidance on using blood from recovered COVID-19 patients to treat new cases.
Coronavirus immunity certificates could permit recovered persons to escape lockdown restrictions.
Regulators and policymakers review old rules and propose new guidelines for rationing ventilators.
FDA clarifies its generic drug approval process in an effort to encourage market competition.
To curb overdoses and drug trafficking, the DEA proposes regulations for a chemical precursor to fentanyl.